These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

403 related articles for article (PubMed ID: 27683045)

  • 1. MELAS Syndrome and Kidney Disease Without Fanconi Syndrome or Proteinuria: A Case Report.
    Rudnicki M; Mayr JA; Zschocke J; Antretter H; Regele H; Feichtinger RG; Windpessl M; Mayer G; Pölzl G
    Am J Kidney Dis; 2016 Dec; 68(6):949-953. PubMed ID: 27683045
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The MELAS mutation m.3243A>G promotes reactivation of fetal cardiac genes and an epithelial-mesenchymal transition-like program via dysregulation of miRNAs.
    Meseguer S; Panadero J; Navarro-González C; Villarroya M; Boutoual R; Comi GP; Armengod ME
    Biochim Biophys Acta Mol Basis Dis; 2018 Sep; 1864(9 Pt B):3022-3037. PubMed ID: 29928977
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [A case of mitochondrial encephalomyopathy (MELAS)].
    Suzuki T; Fujino T; Sugiyama M; Ishida M
    Nihon Jinzo Gakkai Shi; 1996 Feb; 38(2):109-14. PubMed ID: 8717314
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Renal involvement in MELAS syndrome - a series of 5 cases and review of the literature.
    Seidowsky A; Hoffmann M; Glowacki F; Dhaenens CM; Devaux JP; de Sainte Foy CL; Provot F; Gheerbrant JD; Hummel A; Hazzan M; Dracon M; Dieux-Coeslier A; Copin MC; Noël C; Buob D
    Clin Nephrol; 2013 Dec; 80(6):456-63. PubMed ID: 22909780
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Chronic kidney disease, severe arterial and arteriolar sclerosis and kidney neoplasia: on the spectrum of kidney involvement in MELAS syndrome.
    Piccoli GB; Bonino LD; Campisi P; Vigotti FN; Ferraresi M; Fassio F; Brocheriou I; Porpiglia F; Restagno G
    BMC Nephrol; 2012 Feb; 13():9. PubMed ID: 22353239
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ischemic optic neuropathy as first presentation in patient with m.3243 A > G MELAS classic mutation.
    Scarcella S; Dell'Arti L; Gagliardi D; Magri F; Govoni A; Velardo D; Mainetti C; Minorini V; Ronchi D; Piga D; Comi GP; Corti S; Meneri M
    BMC Neurol; 2023 Apr; 23(1):165. PubMed ID: 37095452
    [TBL] [Abstract][Full Text] [Related]  

  • 7. MELAS syndrome: Clinical manifestations, pathogenesis, and treatment options.
    El-Hattab AW; Adesina AM; Jones J; Scaglia F
    Mol Genet Metab; 2015; 116(1-2):4-12. PubMed ID: 26095523
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Detection rates and phenotypic spectrum of m.3243A>G in the MT-TL1 gene: a molecular diagnostic laboratory perspective.
    Chin J; Marotta R; Chiotis M; Allan EH; Collins SJ
    Mitochondrion; 2014 Jul; 17():34-41. PubMed ID: 24846800
    [TBL] [Abstract][Full Text] [Related]  

  • 9. New Variant of MELAS Syndrome With Executive Dysfunction, Heteroplasmic Point Mutation in the
    Endres D; Süß P; Maier SJ; Friedel E; Nickel K; Ziegler C; Fiebich BL; Glocker FX; Stock F; Egger K; Lange T; Dacko M; Venhoff N; Erny D; Doostkam S; Komlosi K; Domschke K; Tebartz van Elst L
    Front Immunol; 2019; 10():412. PubMed ID: 30949164
    [No Abstract]   [Full Text] [Related]  

  • 10. Impediments to Heart Transplantation in Adults With MELAS
    Di Toro A; Urtis M; Narula N; Giuliani L; Grasso M; Pasotti M; Pellegrini C; Serio A; Pilotto A; Antoniazzi E; Rampino T; Magrassi L; Valentini A; Cavallini A; Scelsi L; Ghio S; Abelli M; Olivotto I; Porcu M; Gavazzi A; Kodama T; Arbustini E
    J Am Coll Cardiol; 2022 Oct; 80(15):1431-1443. PubMed ID: 36202533
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Kidney involvement in MELAS syndrome: Description of 2 cases.
    Alcubilla-Prats P; Solé M; Botey A; Grau JM; Garrabou G; Poch E
    Med Clin (Barc); 2017 Apr; 148(8):357-361. PubMed ID: 28283275
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mitochondrial DNA mutation "m.3243A>G"-Heterogeneous clinical picture for cardiologists ("m.3243A>G": A phenotypic chameleon).
    Niedermayr K; Pölzl G; Scholl-Bürgi S; Fauth C; Schweigmann U; Haberlandt E; Albrecht U; Zlamy M; Sperl W; Mayr JA; Karall D
    Congenit Heart Dis; 2018 Sep; 13(5):671-677. PubMed ID: 30133155
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A case of mitochondrial cytopathy with a typical point mutation for MELAS, presenting with severe focal-segmental glomerulosclerosis as main clinical manifestation.
    Kurogouchi F; Oguchi T; Mawatari E; Yamaura S; Hora K; Takei M; Sekijima Y; Ikeda Si; Kiyosawa K
    Am J Nephrol; 1998; 18(6):551-6. PubMed ID: 9845835
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Acute myocardial infarction in a patient with MELAS syndrome: a possible link?
    Cosma J; Russo A; Schino S; Belli M; Mango R; Chiricolo G; Martuscelli E; Mariano EG
    Minerva Cardiol Angiol; 2023 Aug; 71(4):374-380. PubMed ID: 35767235
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Modeling Mitochondrial Encephalomyopathy, Lactic Acidosis, and Stroke-Like Episodes Syndrome Using Patient-Derived Induced Neurons Generated by Direct Reprogramming.
    Povea-Cabello S; Villanueva-Paz M; Villalón-García I; Talaverón-Rey M; Álvarez-Cordoba M; Suárez-Rivero JM; Montes MÁ; Rodríguez-Moreno A; Andrade-Talavera Y; Armengol JA; Sánchez-Alcázar JA
    Cell Reprogram; 2022 Oct; 24(5):294-303. PubMed ID: 35802497
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mitochondrial encephalomyopathies preceded by de-Toni-Debré-Fanconi syndrome or focal segmental glomerulosclerosis.
    Mochizuki H; Joh K; Kawame H; Imadachi A; Nozaki H; Ohashi T; Usui N; Eto Y; Kanetsuna Y; Aizawa S
    Clin Nephrol; 1996 Nov; 46(5):347-52. PubMed ID: 8953126
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mitochondrial 3243A > G mutation confers pro-atherogenic and pro-inflammatory properties in MELAS iPS derived endothelial cells.
    Pek NMQ; Phua QH; Ho BX; Pang JKS; Hor JH; An O; Yang HH; Yu Y; Fan Y; Ng SY; Soh BS
    Cell Death Dis; 2019 Oct; 10(11):802. PubMed ID: 31641105
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The MELAS mutation m.3243A>G alters the expression of mitochondrial tRNA fragments.
    Meseguer S; Navarro-González C; Panadero J; Villarroya M; Boutoual R; Sánchez-Alcázar JA; Armengod ME
    Biochim Biophys Acta Mol Cell Res; 2019 Sep; 1866(9):1433-1449. PubMed ID: 31195049
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Mitochondrial genome analysis in the probands of six Chinese families with MELAS].
    Liu L; Yuquan S; Baorong Z; Pingping J; Ailian D; Minxin G
    Yi Chuan; 2014 Nov; 36(11):1159-67. PubMed ID: 25567874
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Five non-mitochondrial myopathy, encephalopathy, lactic acidosis and stroke-like episodes phenotype adult patients with m.3243A>G mutation after kidney transplantation: follow-up and review of the literature.
    de Laat P; van Engelen N; Wetzels JF; Smeitink JAM; Janssen MCH
    Clin Kidney J; 2019 Dec; 12(6):840-846. PubMed ID: 31807297
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.